VYNE Therapeutics Inc (NASDAQ: VYNE) kicked off on Tuesday, up 11.86% from the previous trading day, before settling in for the closing price of $0.36. Over the past 52 weeks, VYNE has traded in a range of $0.28-$4.30.
During the last 5-year period, the sales growth of Healthcare Sector giant was 65.87%. While this was happening, its average annual earnings per share was recorded 15.05%. With a float of $31.15 million, this company’s outstanding shares have now reached $31.77 million.
VYNE Therapeutics Inc (VYNE) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of VYNE Therapeutics Inc is 6.43%, while institutional ownership is 10.18%. The most recent insider transaction that took place on Jan 15 ’25, was worth 43,800. In this transaction Director of this company bought 15,000 shares at a rate of $2.92, taking the stock ownership to the 51,472 shares.
VYNE Therapeutics Inc (VYNE) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.28 earnings per share (EPS), higher than consensus estimate (set at -0.3) by 0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.18 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 15.05% per share during the next fiscal year.
VYNE Therapeutics Inc (NASDAQ: VYNE) Trading Performance Indicators
Take a look at VYNE Therapeutics Inc’s (VYNE) current performance indicators. Last quarter, stock had a quick ratio of 8.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 25.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.79, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.92 in one year’s time.
Technical Analysis of VYNE Therapeutics Inc (VYNE)
Looking closely at VYNE Therapeutics Inc (NASDAQ: VYNE), its last 5-days average volume was 1.67 million, which is a jump from its year-to-date volume of 1.22 million. As of the previous 9 days, the stock’s Stochastic %D was 39.10%.
During the past 100 days, VYNE Therapeutics Inc’s (VYNE) raw stochastic average was set at 9.30%, which indicates a significant decrease from 73.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0282 in the past 14 days, which was lower than the 0.0304 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3701, while its 200-day Moving Average is $0.9005. However, in the short run, VYNE Therapeutics Inc’s stock first resistance to watch stands at $0.4201. Second resistance stands at $0.4376. The third major resistance level sits at $0.4711. If the price goes on to break the first support level at $0.3691, it is likely to go to the next support level at $0.3356. Now, if the price goes above the second support level, the third support stands at $0.3181.
VYNE Therapeutics Inc (NASDAQ: VYNE) Key Stats
The company with the Market Capitalisation of 13.40 million has total of 33,286K Shares Outstanding. Its annual sales at the moment are 500 K in contrast with the sum of -39,830 K annual income. Company’s last quarter sales were recorded 170 K and last quarter income was -7,280 K.
